Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902219-12-000004
Filing Date
2012-01-10
Accepted
2012-01-10 13:14:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 DISCLOSURE DOCUMENT sec_filing.htm SC 13G 17892
  Complete submission text file 0000902219-12-000004.txt   19596
Mailing Address 280 CONGRESS STREET BOSTON MA 02210
Business Address 280 CONGRESS STREET BOSTON MA 02210 6179515000
WELLINGTON MANAGEMENT CO LLP (Filed by) CIK: 0000902219 (see all company filings)

EIN.: 042683227 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 4939 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4939 DIRECTORS PLACE SAN DIEGO CA 92121 858-652-6500
Ardea Biosciences, Inc./DE (Subject) CIK: 0001103390 (see all company filings)

EIN.: 943200380 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-59411 | Film No.: 12519410
SIC: 2834 Pharmaceutical Preparations